Hence, the observed reductions of TGFβ, FGF2, IL-6 and HGF can not only be due to the reduction of tumor-infiltrating CAFs but also due to quantitative and/or qualitative changes in other intratumoral cell populations such as reduced numbers of ECs due to an anti-angiogenic effect of the treatments. This evidence concerns the gene TBX1 and neoplasm.